インフルエンザの進化の生態学的および免疫学的決定要因
Neil M Ferguson1, Alison P Galvani, Robin M Bush
1Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK. neil.ferguson@ic.ac.uk
Nature
|March 28, 2003
まとめ
インフルエンザウイルスは急速に進化し,毎年ワクチンを更新する必要があります. 短命の免疫は,高い変異率にもかかわらず,インフルエンザが低い多様性を維持し,ドリフトとシフトダイナミクスの両方に影響を与えることを説明します.
科学分野:
- ウイルス学 ウイルス学 ウイルス学
- エピデミオロジー エピデミオロジー
- 免疫学 免疫学とは
背景:
- インフルエンザは,継続的なウイルスの進化によって引き起こされる,重要な世界的な罹病率と死亡率を引き起こす.
- 抗原ドリフトは,毎年ワクチンの再編成を必要とし,抗原シフトはパンデミックを引き起こす可能性があります.
- 高い変異率と伝染性にもかかわらず,インフルエンザの遺伝的多様性が低いことはパラドックスです.
研究 の 目的:
- インフルエンザの抗原ドリフトとシフトダイナミクスに影響を与える生態学的および免疫学的要因を探求する.
- インフルエンザの系統内でウイルスの多様性が低い状態を維持するメカニズムを理解する.
- ウイルスの進化パターンを流行病学的観察と調和させる.
主な方法:
- 疫学的動態とウイルス配列の進化を組み込んだ数学的モデルの開発.
- 配列レベルでのウイルス進化の分析.
- モデルアウトプットと,世界的なインフルエンザの監視と,系統遺伝学的データとのマッチング.
主要な成果:
- 短命で,株を超越する免疫は,重要な要因として特定されています.
- この免疫は,宿主集団内のウイルス多様性を効果的に制限します.
- このモデルは,インフルエンザのドリフトとシフトのダイナミクスの重要な側面をうまく説明しています.
結論:
- 短命の免疫は,インフルエンザの遺伝的多様性を調節するために不可欠です.
- この発見は,抗原ドリフトとシフトの両方に統一された説明を提供します.
- これらのダイナミクスを理解することは,インフルエンザの制御とワクチンの開発に不可欠です.
関連する概念動画
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...


